INTRODUCTION
line was obtained from the American type culture collection (Manassas, VA, U.S.A.). K562 CML cells are commonly used for investigating purging effects because the AS-ONDs used in the experiments were derived from antisense sequences directed at the CML-related bcr-abl oncogene. The breakpoint of the bcr-abl oncogene in K562 cell is b3a2.
ODN structure and INF-
AS-ODNs were purchased from Bioneer (Okchun, Korea). All AS-ODNs were 18-mers or 24-mers spanning either the b3a2 or the b2a2 bcr-abl fusion breakpoint (Table 1) . In addition to AS-ODNs specific to the breakpoint, two to four nucleotides substituted missense ODNs were also studied. All AS-ODNs but two were phosphodiester-linked structure (PO), and the two AS-ODNs were phosphorothioate-linked (PS).
K562 cells (10 5 ) were seeded into a 24-well cell culture plate in RPMI-1640 (Gibco BRL, Gaithersburg, U.S.A.) medium supplemented with 10% fetal bovine serum (FBS). The cells were incubated with 40 g/mL of each AS-ODN at the start of the culture period and the same dose was added to the medium 24, 48, and 72 hr. The control groups were incubated in the same condition in the absence of AS-ODNs.
INF-was incubated at a concentration of either 300,000 U/mL or 30,000 U/mL. At intervals, part of the nonadhesive cells was harvested and the viable cell number was determined by trypan blue elusion test, then used for the next experiment.
Flow cytometric analysis for intracellular uptake of AS-ODN
A total of 1.5×10 6 cells in 60 L of RPMI/FBS were incubated with 40 g/mL FITC-labeled b3a2 AS-ODN at 37℃ for up to 6 hr. Ten L aliquots were removed at 0, 1, 2, 4, and 5 hr into 1 mL of RPMI/FBS containing 10 g/mL propidium iodide at 4℃ for 10 min and washed three times in RPMI/FBS.
Fluorescence was measured on a FACStar plus (Becton Dickinson Immunocytometry systems, San Jose, CA, U.S.A.) and uptake was recorded as the mean fluorescence intensity (MFI).
The permeabilization enhancing techniques using SL-O was essentially that of Barry et al. (5) . Briefly, after washing in serum-free RPMI medium, 1.5×10 6 K562 cells were exposed to dithiothreitol (DTT)-activated SL-O at 1,000 IU/mL or 100 IU/mL concentration at 37℃. Thirty minutes later, cells were washed with RPMI/FBS twice and used for flow cytometric analysis as previously mentioned. We also used the liposome formation technique to enhance permeabilization. FITC-labeled AS-ODNs and lipofectin (Gibco BRL, Gaitherburg, U.S.A.) were mixed for 15 min at 37℃, using sufficient AS-ODNs to achieve a final concentration of 2 mol/L after addition to the cell suspensions. 1.5×10 6 K562 cells were suspended in 200 L RPMI/FBS and incubated with AS-ODN/lipofectin mixture for 15 min at 37℃. Subsequently, the intracellular uptake of this mixture was analyzed by FACS. No attempt was made to remove the lipofectin.
MTT assay
Thirty thousand cells pretreated with AS-ODNs or IFNwere seeded into a 96-well cell culture plate in 200 L RPMI/ FBS. Two g/mL MTT [3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; Sigma, St Louis, MO, U.S.A.] solubilized in 0.15 M PBS was added and incubated for 4 hr at 37℃. After solubilizing the formazan with 100 L 0.04N HCl-isopropanol, the absorbance at 540 nm was measured by using a microplate reader (Molecular Devices, Gaitherburg, U.S.A.).
Colony-forming unit for culture (CFU-C) CFU-C assays were performed using a complete methylcellulose medium with recombinant cytokines for colony assays of human cells (Methocult GF-H4434; StemCell Technologies, Vancouver, BC, Canada). It contains 1.0% methylcellulose, 30% fetal bovine serum, 1% BSA, 10 M 2-mercaptoethanol, 2 mM L-glutamine, 10 ng/mL recombinant human (rh) interleukin-3, 10 ng/mL rh granulocyte-monocyte colony stimulating factor, 50 ng/mL rh stem cell factor, 3 units/mL rh erythopoietin in Iscove's Modified Dulbecco's medium (IMDM; GibcoBRL, Gaithersburg, MD, U.S.A.).
MNCs (2×10 5 ) were resuspended in plastic 35 mm tissue culture dishes containing 1 mL methylcellulose medium and cultured at 37℃ in 100% humidified 5% CO2 in air. After 2 weeks, CFU-Cs were counted according to color, size, and marginal shape.
Reverse transcription polymerase chain reaction (RT-PCR) analysis
Total RNAs were extracted by acid-guanidinium phenol chloroform method using RNAzol B (TEL-TEST, Friendswood, U.S.A.).
Two g RNAs were reverse transcribed in a mixture of 1×
18-mers b3a2 antisense 5′ -GAA-GGG-CTT-TTG-AAC-TCT-3′ B3a2 missense(TAT) 5′ -GAA-GTG-CTG-TTG-CAC-TAT-3′ b3a2 missense 5′ -GAA-GTG-CTG-TTG-CAC-TAT-3′ b2a2 antisense 5′ -GAA-GGG-CTT-CTT-CCT-TAT-3′ b2a2 missense 5′ -GAA-CGG-CAT-CTA-CGT-TAT-3′ 24-mers b3a2 antisense 5′ -GCT-GAA-GGG-CTT-TTG-AAC-TCT-GCT-3′ b2a2 antisense 5′ -GCT-GAA-GGG-CTT-CTT-CCT-TAT-TGA-3′ For the detection of bcr-abl mRNA, 200 ng cDNA was amplified in a mixture of 1×Taq DNA polymerase buffer [20 mM Tris-HCl (pH 7.5), 100 mM KCl, 1 mM DTT, 0.1 mM EDTA, 0.5% Tween-20, 0.5% Nonidet P40, 50% glycerol, 1.5 mM MgCl2], 1U Taq DNA polymerase, 250 M each dNTPs, and 250 nM each primers for 30 cycles of 1 min denaturation at 94℃, 1 min annealing at 61℃, and 2 min extension at 72℃. For the nested PCR, another 30 cycles at 68℃ annealing temperature was added. In order to verify the quantity of mRNA in each sample, -actin mRNA was also amplified to the same concentration for 35 cycles of 1 min denaturation at 94℃, 1 min annealing at 65℃, and 2 min extension at 72℃. After confirming bcr-abl mRNA expression, the amount of expression was measured by densitometer (GS-700; BioRad, Hercules, CA, U.S.A.)
The primer sequences used were as follows (Table 1) ; for bcr-abl, 5′ -GAAGTGTTTCAGAAG CTT CTCC-3′ (outer sense; B1), 5′ -TGATTATAGCCTAAGACCCGGA-3′ (outer antisense; A3), 5′ -TGGAGCTGCAGATGCTGACCAAC-TCG-3′ (inner sense; B2), 5′ -ATCTCCACTGGC CACAA-AATCATACA-3′ (inner antisense; A4), for -actin, 5′ -GT-GGGGCGCCCCA GGCACCA-3′ (sense), 5′ -GTCCTTA-ATGTCACGCACGATTTC-3′ (antisense).
Statistical Analysis
Data were represented by mean±SD. A two-group comparison was based on a 2-tailed paired sample t test. A p value <0.05 was considered statistically significant.
RESULTS

FACS analysis for the detection of AS-ODNs uptake
The frequency distribution of fluorescent AS-ODNs into K562 cells was compared to various purging agents. Fig. 1 illustrates the AS-ODNs uptake into K562 CML cells exposed continuously to b3a2-directed ODN of various treatments for 5 hr. The uptake is expressed as the mean fluorescence intensity (MFI) of fluorescein-labeled AS-ODNs per cell (Fig. 1A) . AS-ODNs uptakes increased sharply with time to 1 hr following incubation and then maintained a plateau until 5 hr in all groups. There were no differences in AS-ODNs uptake between the simple diffusion group and the SL-O treatment group. Additionally, no differences were seen in the concentration of SL-O. Transfection by lipofectin treatments was more efficient than the other groups in intracellular uptake of AS-ODNs (p<0.05) (Fig. 1B) .
Cytotoxic effects of various types of purging agents measured by cell count assay Cell numbers were increased until 72 hr and then decreased in untreated control group. The cytotoxic effects of AS-ODNs groups were superior to those of INF-groups at 48 hr, 72 hr, and 96 hr (p<0.05). AS-ODNs groups were examined for their cytotoxic effects, divided into three aspects according to the breakpoint specific or not specific for target gene, chemical structure linked to PO or PS form, and the length of AS-ODNs for 18-or 24-mers. The purging effects of AS-ODNs were more superior in the PS type, long chain and breakpoint specific, but there were no statistically significant differences (Fig. 2) .
Cytotoxic effects of various types of purging agents measured by MTT assay
We also used an MTT assay to measure the cytotoxic effects of various kinds of AS-ODNs. As in cell count assay, in MTT test, the cytotoxic effects of the AS-ODNs groups were also superior to those of INF-groups (p<0.05). AS-ODNs inhibited the proliferation of K562 cells in a time-dependent manner, especially the PS type, long chain and b3a2, but there were no significant differences among various types of AS-ODNs (Fig. 3) .
Cytotoxic effects of various types of purging agents measured by clonogenic assay
The actual number of colony formation from 10 5 mononuclear K562 cells was 5,290±2,110 in the untreated control group. Incubation with purging agents decreased the number of colonies significantly in all groups. As expected in the AS-ODN group, a significant inhibition of CML clonogenic cells was found. Although INF-inhibited CML clonogenic cells, AS-ODN was a more stronger inhibitor of CML cells. The recovery rate of CFU-C as an untreated control was 64.0% in the INF-group and 26.3% in the AS-ODNs (p<0.05). But we could not find a morphologic variation of colony form according to the purging agents (Fig. 4) .
Inhibitory effects on the expression of bcr-abl mRNA of various purging agents
The effects of various AS-ODNs on the expression of bcr-abl mRNA has been examined by RT-PCR. As shown in Fig. 5 , positive bands were abolished in AS-ODN groups, whereas they were not inhibited in the INF-groups with RT-PCR using bcr-abl primer and mRNA isolated from K562 cells. Time (hr)
Treatment with INF-did not affect the gene expression in K562 cells. However, treatment with AS-ODNs reduced the bcr-abl mRNA expression. In particular, b3a2, (PS) type showed the most profound effects (Fig. 5) .
DISCUSSION
AS-ODN directed to leukemia-specific transcripts has the potential to specifically target the genes with a pathologic role in leukemogenesis while sparing normal hematopoietic cells. The use of bcr-abl AS-ODN may be considered one of the newest approaches for the treatment of CML, and the in vitro treatment before autograft, at the moment, appears to be a clinical application more likely to produce favorable therapeutic outcomes (6) .
Although leukemic cells take up AS-ODN more readily than normal cells for AS-ODN in order to have a worthwhile biologic effect, some means of enhancing cellular uptake is essential (7). Therefore, we examined different strategies for improving the effectiveness of AS-ODN uptake in CML cells (8, 9) .
Liposome formation has been commonly used for effective intracellular delivery of AS-OND. This kind of packaging leads to the formation of micromolecular complexes with a positive charge on the surface, permitting binding to the negatively charged membrane. Following attachment to the cell, the complexes are presumably taken up via endocytosis (2, 4, 10, 11) . In the present study, we discerned that liposome formation with lipofectin of AS-ODNs increased the intracellular delivery of AS-ODN, achieving levels of approximately double.
SL-O permeabilization was also enough to deliver AS-ODNs into the cells. Especially SL-O permeabilization translates into increased biologic effectiveness of AS-ODN in cells, as evidenced by the decreased target mRNA levels (12, 13) . Although treatment with lipofectin resulted in higher intracellular uptake of AS-ODNs than otherwise would have been resulted from simple diffusion, simple diffusion method is enough to deliver AS-ODNs to K562 cells. Furthermore, diffusion is the easiest mode by which purging agents pass across the biologic membrane in vitro. Taking all these into 188 K.H. Ryu, J.Y. Seoh, P.S. Jang, et al. account, we used simple diffusion as a mode to transfer ASODNs into K562 cells. The breakpoint of the Philadelphia chromosome in the K562 cells is b3a2. Thus breakpoint specific AS-ODNs were prepared for the b3a2 type (2, 3). Breakpoint-specific AS-ODN may have a greater purging effectiveness than a nonspecific one. In our study, the breakpoint-specific AS-ODNs of the b3a2 type show most effective purging effects than nonspecific one although there were no statistically significant differences.
The PO types of AS-ODNs are rapidly degraded in vivo by the ubiquitously distributed DNases before they reach their intracellular target RNA. Chemical modifications were therefore made to increase their stability by protection against enzymatic cleavage (14) . The changes made in the chemical structure of the AS-ODNs should not be associated with a decrease in their RNA-binding ability. The most common modified versions of AS-ODNs include the PS type, in which one of the oxygens of the phosphate backbone is substituted by a sulfuration. In mRNA expression of bcr-abl, we demonstrated the differences between chemical structure of ASODNs. The PS type is more effective than the PO type (15) . However, there were no differences between the PS and PO types in the cell count assay and MTT methods.
The length of AS-ODNs is another factor of anti-tumor effects of AS-ODNs. However, we could not find any differences according to the length using 18-mers and 24-mers.
There may be significant differences in the antitumor effects if the size variation is greater (15) .
The clonogenic activities of CML cells were reduced in the AS-ODN b3a2 PS groups but not in the control and INFgroups.
As expected, in methods of analysis, the AS-ODNs group exhibited a superior purging effect to the INF group. Therefore, AS-ODNs provide new anti-CML effects over conventional chemotherapy (13) .
Gewirtz et al. first tried autologous transplantations in CML patients with purged MNCs using AS-ODNs (16) . One of the problems associated with the systemic administration of AS-ODNs in patients with CML may relate to the nonspecific effects of these compounds and possible toxicity toward normal marrow progenitors that could limit their use as in vitro purging agents and as drugs for systemic therapy (17) . Additionally, due to the short living nature of AS-ODNs, we should develop methods of more stable and sustained inhibition of target genes. Moreover, further investigation on the degradation kinetics and biological mechanisms of AS-ODNs are needed further before clinical trials (14, 18) .
The development of more specific and active AS-ODNs and the optimization of in vitro and in vivo treatment conditions may yield improved results in autografted CML patients (19) . 
